Moneycontrol
HomeNewsBusinessCompaniesTo buy 1-2% of $70 bn Japanese pharma mkt: Elder
Trending Topics

To buy 1-2% of $70 bn Japanese pharma mkt: Elder

Elder Pharmaceuticals recently received an accreditation from the Ministry of Health, Japan for their API plant in Maharashtra. In an exclusive interview with CNBC-TV18, Alok Saxena, Director of Elder Pharmaceuticals says that the accreditation is going to help enter grow in the Japanese pharma market.

January 05, 2011 / 12:53 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Elder Pharmaceuticals recently received an accreditation from the Ministry of Health, Japan for their API plant in Maharashtra. In an exclusive interview with CNBC-TV18, Alok Saxena, Director of Elder Pharmaceuticals says that the accreditation is going to help enter grow in the Japanese pharma market.

first published: Jan 4, 2011 05:01 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!